I'm a research scientist and Principal Investigator in the Division of Neuropsychiatry and Interventional Psychiatry at Massachusetts General Hospital and Harvard Medical School. My research focuses on developing and optimizing non-invasive neuromodulation techniques to understand human neurophysiology and advance treatments for neuropsychiatric disorders.
Nonlinear neuroplasticity in human brain stimulation.
Phase-synchronized rTMS+tACS to stabilize intrinsic brain rhythms.
Translation of mechanistic neuromodulation to aging and rehabilitation.
Building upon mechanistic neuromodulation work, I have developed a translational research program identifying EEG-based biomarkers and machine-learning predictors for clinical symptomology and neuromodulation response. My ongoing work involves building computational neuroimaging processing pipelines for ongoing neuromodulation clinical trials in major depression (MDD), ADHD, OCD, Alzheimer's Disease, and substance-use disorders (SUDs). Recent findings have identified reproducible EEG signatures associated with clinical symptoms, supporting the feasibility of data-driven precision neuromodulation wherein quantitative EEG metrics guide parameter selection.